Literature DB >> 23885733

Implementation of a breast cancer genetic service in South Africa - lessons learned.

Mardelle Schoeman1, Justus P Apffelstaedt, Karin Baatjes, Michael Urban.   

Abstract

BACKGROUND: Genetic testing for BRCA mutations has been available in the Western Cape of South Africa since 2005, but practical implementation of genetic counselling and testing has been challenging.
OBJECTIVE: To describe an approach to breast cancer genetic counselling and testing developed in a resource-constrained environment at Tygerberg Hospital in Cape Town, Western Cape.
METHODS: Genetic counselling is offered in a stepwise manner to our diverse patient population, with a focus on affected probands, and subsequent cascade testing. A record review of BRCA testing between 2005 and 2011 was performed. RESULTS; During this period 302 probands received genetic testing, with increasing numbers tested over time. Of 1 520 women treated for breast cancer since 2008, 226 (14.9%) accepted BRCA testing, and 39 tested positive (17.3% of those tested, and 2.6% of all women). Common founder mutations were detected in 11.9% of women (36/302), and comprised 73% (36/49) of mutations detected. Cascade testing increased after 2010: 16 female and 4 male family members of 19 probands accepted testing, with 6 positives being detected.
CONCLUSION: A protocol-driven approach focusing on probands, with initial pre-test counselling by primary care staff has proven effective in establishing the service. Involvement of a clinical geneticist/genetic counsellor has permitted more detailed post-test counselling and increased use of cascade testing.

Entities:  

Mesh:

Year:  2013        PMID: 23885733     DOI: 10.7196/samj.6814

Source DB:  PubMed          Journal:  S Afr Med J


  10 in total

1.  Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013.

Authors:  Babatunde O Adedokun; Christopher O Olopade; Olufunmilayo I Olopade
Journal:  Glob Health Action       Date:  2016-05-12       Impact factor: 2.640

Review 2.  Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine.

Authors:  Allison Silverstein; Rachita Sood; Ainhoa Costas-Chavarri
Journal:  Int J Breast Cancer       Date:  2016-06-16

3.  Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.

Authors:  Alsmawal A Elimam; Mohamed Elmogtba Mouaweia Mohamed Aabdein; Mohamed El-Fatih Moly Eldeen; Hisham N Altayb; Mohamed Adel Taha; Mohammed N Nimir; Mohamed D Dafaalla; Musaab M Alfaki; Mohamed A Abdelrahim; Abdelmohaymin A Abdalla; Musab I Mohammed; Mona Ellaithi; Muzamil Mahdi Abdel Hamid; Mohamed Ahmed Salih Hassan
Journal:  BMC Med Genet       Date:  2017-08-16       Impact factor: 2.103

4.  Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer.

Authors:  Jean Pascal Demba Diop; Rokhaya Ndiaye Diallo; Violaine Bourdon-Huguenin; Ahmadou Dem; Doudou Diouf; Mamadou Moustapha Dieng; Seydi Abdoul Ba; Yacouba Dia; Sidy Ka; Babacar Mbengue; Alassane Thiam; Oumar Faye; Papa Amadou Diop; Hagay Sobol; Alioune Dieye
Journal:  BMC Med Genet       Date:  2019-05-06       Impact factor: 2.103

5.  Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.

Authors:  Jaco Oosthuizen; Maritha J Kotze; Nicole Van Der Merwe; Ettienne J Myburgh; Phillip Bester; Nerina C van der Merwe
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

6.  Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience.

Authors:  Nerina C Van der Merwe; Herkulaas MvE Combrink; Kholiwe S Ntaita; Jaco Oosthuizen
Journal:  Front Genet       Date:  2022-04-08       Impact factor: 4.772

7.  BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.

Authors:  F Z Francies; T Wainstein; K De Leeneer; A Cairns; M Murdoch; S Nietz; H Cubasch; B Poppe; T Van Maerken; B Crombez; I Coene; R Kerr; J P Slabbert; A Vral; A Krause; A Baeyens; K B M Claes
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

8.  In Their Own Words: A Qualitative Study of Kenyan Breast Cancer Survivors' Knowledge, Experiences, and Attitudes Regarding Breast Cancer Genetics.

Authors:  Siwon Lee; Amal Gedleh; Jessica A Hill; Seemi Qaiser; Yvonne Umukunda; Philip Odiyo; Grace Kitonyi; Helen Dimaras
Journal:  J Glob Oncol       Date:  2017-12-04

9.  Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.

Authors:  Rispah Torrorey-Sawe; Nicole van der Merwe; Simeon Kipkoech Mining; Maritha J Kotze
Journal:  Front Genet       Date:  2020-03-06       Impact factor: 4.599

10.  The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.

Authors:  Nerina C van der Merwe; Jaco Oosthuizen; Magdalena Theron; George Chong; William D Foulkes
Journal:  BMC Cancer       Date:  2020-05-06       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.